Praneeth Goli, Thomas A. Kocarek, Christopher D. Kassotis
{"title":"Metabolism disrupting effects in human pre-adipocytes: Influence of donor sex and body composition","authors":"Praneeth Goli, Thomas A. Kocarek, Christopher D. Kassotis","doi":"10.1016/j.taap.2025.117463","DOIUrl":null,"url":null,"abstract":"<div><div>There is growing attention on the global, worsening rates of metabolic disorders, including obesity. Numerous attempted interventions have provided only modest effects, with current rates of obesity in the United States remaining high (e.g., 42.4 % of adults and 8.9 % of infants and toddlers). Metabolism-disrupting chemicals (MDCs) are one proposed causal factor and are chemicals that can disrupt adipocyte development and differentiation in vitro and/or metabolism in vivo (e.g., increased weight, adipose). High costs prohibit comprehensive rodent screening for MDCs, necessitating the use of in vitro models to better screen and prioritize chemicals for higher-order testing. This study aimed to evaluate human adipose-derived pre-adipocytes as a potential model for determining MDCs, focusing on donor sex and body composition impacts on adipogenesis. Adipogenesis assays were performed on male and female human subcutaneous pre-adipocytes isolated from lean and obese donors. The response of each donor cell line to hormones and chemicals known to promote adipogenesis was examined, evaluating both sex and body composition impacts on triglyceride accumulation and pre-adipocyte proliferation. Results showed considerable variability between and within donor groups, complicating the findings of MDCs' consistent effects. While human pre-adipocyte models appear to offer a closer mimic of real-life responses, a careful assessment of variability is needed. Despite challenges, this model provides valuable insights into how MDCs impact individuals variably based on sex, body composition, and genetic makeup.</div></div>","PeriodicalId":23174,"journal":{"name":"Toxicology and applied pharmacology","volume":"503 ","pages":"Article 117463"},"PeriodicalIF":3.4000,"publicationDate":"2025-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Toxicology and applied pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0041008X2500239X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
There is growing attention on the global, worsening rates of metabolic disorders, including obesity. Numerous attempted interventions have provided only modest effects, with current rates of obesity in the United States remaining high (e.g., 42.4 % of adults and 8.9 % of infants and toddlers). Metabolism-disrupting chemicals (MDCs) are one proposed causal factor and are chemicals that can disrupt adipocyte development and differentiation in vitro and/or metabolism in vivo (e.g., increased weight, adipose). High costs prohibit comprehensive rodent screening for MDCs, necessitating the use of in vitro models to better screen and prioritize chemicals for higher-order testing. This study aimed to evaluate human adipose-derived pre-adipocytes as a potential model for determining MDCs, focusing on donor sex and body composition impacts on adipogenesis. Adipogenesis assays were performed on male and female human subcutaneous pre-adipocytes isolated from lean and obese donors. The response of each donor cell line to hormones and chemicals known to promote adipogenesis was examined, evaluating both sex and body composition impacts on triglyceride accumulation and pre-adipocyte proliferation. Results showed considerable variability between and within donor groups, complicating the findings of MDCs' consistent effects. While human pre-adipocyte models appear to offer a closer mimic of real-life responses, a careful assessment of variability is needed. Despite challenges, this model provides valuable insights into how MDCs impact individuals variably based on sex, body composition, and genetic makeup.
期刊介绍:
Toxicology and Applied Pharmacology publishes original scientific research of relevance to animals or humans pertaining to the action of chemicals, drugs, or chemically-defined natural products.
Regular articles address mechanistic approaches to physiological, pharmacologic, biochemical, cellular, or molecular understanding of toxicologic/pathologic lesions and to methods used to describe these responses. Safety Science articles address outstanding state-of-the-art preclinical and human translational characterization of drug and chemical safety employing cutting-edge science. Highly significant Regulatory Safety Science articles will also be considered in this category. Papers concerned with alternatives to the use of experimental animals are encouraged.
Short articles report on high impact studies of broad interest to readers of TAAP that would benefit from rapid publication. These articles should contain no more than a combined total of four figures and tables. Authors should include in their cover letter the justification for consideration of their manuscript as a short article.